To accommodate the increased vaccine demand during the outbreak, Bavarian Nordic expanded its manufacturing capacity. As part ...
Bavarian Nordic will cease work on an experimental cancer vaccine in early-stage testing and no longer invest in oncology, announcing Wednesday plans to instead prioritize its infectious disease ...
Janssen has signed a new deal with Bavarian Nordic worth up to $836 million to develop target vaccines for hepatitis B and HIV. The projects will combine Bavarian Nordic’s MVA-BN technology with ...
A recommendation to expand the number of Americans encouraged to get an mpox vaccine has not yet been accepted by the CDC's ...
During the outbreak, Bavarian Nordic supplied its mpox vaccine under emergency use provisions to countries where the vaccine was not approved, and which previously had not stockpiled the vaccine.
(Reuters) -Denmark-based Bavarian Nordic said on Saturday it was ending its respiratory syncytial virus (RSV) vaccine programme as its Phase 3 clinical trial did not meet all the primary goals of ...
Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS ...
In February, Bavarian Nordic announced that the Committee for ... the Company’s investigational chikungunya vaccine. The table below presents the actual, audited financial results for 2023 ...
A global shortage in the supply of a vaccine being used to protect against severe illness for monkeypox has spurred the U.S. to negotiate new terms with the sole manufacturer, Bavarian Nordic.
During the outbreak, Bavarian Nordic supplied its mpox vaccine under emergency use provisions to countries where the vaccine was not approved, and which previously had not stockpiled the vaccine.
About Bavarian Nordic Bavarian Nordic is a fully integrated vaccine company with a mission to protect and save lives through innovative vaccines. We are a global leader in smallpox and mpox ...
During the outbreak, Bavarian Nordic supplied its mpox vaccine under emergency use provisions to countries where the vaccine was not approved, and which previously had not stockpiled the vaccine. In ...